# A Study of Rusfertide in Japanese Adults With Polycythemia Vera

Source: https://onco.cc/trials/nct07648030/  
OnCo record `nct07648030` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Rusfertide in myeloproliferative neoplasms, run by Takeda, now recruiting.

## Summary

A Study of Rusfertide in Japanese Adults With Polycythemia Vera is a phase 2 interventional study registered as NCT07648030 by Takeda, with 9 participants planned, started 2026-07-14 and due to reach its primary completion in 2027-10-28. Interventions recorded: Rusfertide.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07648030
- Phase: 2
- Setting: A Phase 2 Open-label Trial to Evaluate the Efficacy and Safety of Rusfertide in Japanese Patients With Polycythemia Vera
- Sponsor: Takeda
- Enrolled: 9

## Sources

- ClinicalTrials.gov NCT07648030: https://clinicaltrials.gov/study/NCT07648030

## Connected records

- cancers: [Myeloproliferative neoplasms (PV, ET, myelofibrosis)](https://onco.cc/cancers/myeloproliferative-neoplasms/)
- drugs: [Rusfertide](https://onco.cc/drugs/rusfertide/)
- companies: [Takeda](https://onco.cc/companies/takeda/)

---
JSON: https://onco.cc/api/v1/entities/nct07648030.json